Thailand FDA + Thai-domestic vendors — Milo-Lab and Bangkok Peptides

The Thai FDA (FDA Thailand, sometimes abbreviated TFDA) regulates pharmaceuticals under the Drug Act B.E. 2510 (1967) and subsequent amendments. The framework is moderate-permissive compared to neighbouring jurisdictions: Thailand has not specifically scheduled BPC-157 (unlike Singapore), and customs enforcement on research-use-only declarations is notably less aggressive than HSA / SAHPRA / NAFDAC frameworks. The Drug Act's schedules apply to controlled and dangerous drugs; research peptides without therapeutic indication generally do not fall under specific scheduling.

Two Thailand-domestic vendors operate openly: Milo-Lab Thailand and Bangkok Peptides. Milo-Lab is the larger of the two, with HPLC + LC-MS verified COAs, THB pricing, and Thai-domestic warehouse offering 1–3 day delivery within Thailand and 3–7 days regionally across Southeast Asia. Bangkok Peptides specialises in third-party Janoshik testing — independent verification rare in the SEA market. Both maintain research-use-only labelling and have not attracted Thai FDA enforcement actions.

For Thai residents, the domestic vendor option is operationally cleanest: no customs friction, THB pricing eliminates FX risk, PromptPay accepted (Thailand's instant payment system), Thai-language customer support available, and same-day or next-day delivery within Bangkok metropolitan area. Milo-Lab pricing is meaningfully cheaper than international vendors — BPC-157 5 mg from $15 USD vs $20-40 from international vendors.

Thailand also functions as a regional entrepôt for SEA peptide research. Milo-Lab and Bangkok Peptides ship to Indonesia, Malaysia, Philippines, Vietnam, Cambodia, and Laos with 3–7 day regional delivery. Cross-border SEA shipping from Thai-domestic vendors faces less customs friction than international (Western) origins because the shipments declare as Thai-origin commerce, not international pharmaceutical imports. This makes Thailand a practical hub for cross-border SEA peptide research.

For institutional researchers in Thailand — Mahidol, Chulalongkorn, KMUTT, Khon Kaen — the Thai FDA framework includes a research permit pathway under the Drug Act allowing universities to import non-registered substances for documented research. The institutional pathway is moderately developed; most academic Thai peptide research uses Milo-Lab or Bangkok Peptides directly without invoking the formal research permit, given the research-use-only operational tolerance.

Thailand's anti-doping authority is the Doping Control Agency Thailand (DCA), which is WADA-aligned. Thai athletes in tested sports (football Thai League, Muay Thai championship competitions, athletics SEA Games) face WADA framework testing. Research peptide positives sanctioned under WADA S0; BPC-157 named explicit since 2022. Sanctions are 2-year ban for first offence consistent with WADA framework.

For non-Thai SEA researchers (Indonesia, Malaysia, Philippines, Vietnam buyers ordering from Milo-Lab Thailand or Bangkok Peptides), the practical reality is: Thai-domestic vendors ship cross-border with reasonable success rates. Bangkok Peptides specifically supports international payment methods (cryptocurrency, plus regional bank transfers); Milo-Lab supports PromptPay for Thai buyers and standard international payment for non-Thai. Combined with Thailand's moderate-permissive framework, Bangkok-origin shipments often clear neighbouring SEA customs better than Western or China origins.